224 related articles for article (PubMed ID: 26632908)
1. Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China.
Shen Y; Wang J; Wang Z; Qi T; Song W; Tang Y; Liu L; Zhang R; Lu H
Medicine (Baltimore); 2015 Dec; 94(48):e2201. PubMed ID: 26632908
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
3. The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.
Liu S; Wei B; Liang W; Chen T; Deng L; Zhao M; Wan J
Front Public Health; 2023; 11():1161503. PubMed ID: 37181701
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria--Implications for Care.
Kuti MA; Adesina OA; Awolude OA; Ogunbosi BO; Fayemiwo SA; Akinyemi JO; Adetunji AA; Irabor AE; Odaibo GN; Prosper O; Taiwo BO; Olaleye D; Murphy RL; Kanki P; Adewole IF
J Int Assoc Provid AIDS Care; 2015; 14(4):355-9. PubMed ID: 25331224
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
Muhammad S; Sani MU; Okeahialam BN
Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy.
Li X; Song X; Han Y; Qiu Z; Cao W; Li T
BMC Infect Dis; 2023 Sep; 23(1):598. PubMed ID: 37705002
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia in people living with HIV-AIDS in a tertiary hospital in South-East Nigeria.
Anyabolu EN
Pan Afr Med J; 2017; 28():204. PubMed ID: 29610642
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study.
Agu CE; Uchendu IK; Nsonwu AC; Okwuosa CN; Achukwu PU
BMC Public Health; 2019 Aug; 19(1):1143. PubMed ID: 31429736
[TBL] [Abstract][Full Text] [Related]
13. Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey.
Hejazi N; Rajikan R; Choong CL; Sahar S
BMC Public Health; 2013 Aug; 13():758. PubMed ID: 23947428
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.
Liu X; Yu S; Mao Z; Li Y; Zhang H; Yang K; Zhang H; Liu R; Qian X; Li L; Bie R; Wang C
Lipids Health Dis; 2018 May; 17(1):119. PubMed ID: 29788966
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.
Zhang M; Deng Q; Wang L; Huang Z; Zhou M; Li Y; Zhao Z; Zhang Y; Wang L
Int J Cardiol; 2018 Jun; 260():196-203. PubMed ID: 29622441
[TBL] [Abstract][Full Text] [Related]
16. [Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions].
Gao Y; Zhong XN; Yang YH; Tian KC
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):432-5. PubMed ID: 22883098
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy.
Innes S; Abdullah KL; Haubrich R; Cotton MF; Browne SH
Pediatr Infect Dis J; 2016 Jan; 35(1):e1-7. PubMed ID: 26421804
[TBL] [Abstract][Full Text] [Related]
18. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression.
Kanjanavanit S; Puthanakit T; Vibol U; Kosalaraksa P; Hansudewechakul R; Ngampiyasakul C; Wongsawat J; Luesomboon W; Wongsabut J; Mahanontharit A; Suwanlerk T; Saphonn V; Ananworanich J; Ruxrungtham K;
Antivir Ther; 2011; 16(8):1351-5. PubMed ID: 22155918
[TBL] [Abstract][Full Text] [Related]
20. Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study.
Wang Q; Ding H; Xu J; Geng W; Liu J; Guo X; Kang J; Li X; Jiang Y; Shang H
Lipids Health Dis; 2016 Sep; 15(1):149. PubMed ID: 27600391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
